| Following on from the FT's long-standing Global Pharmaceutical Conference, the inaugural FT Global Biotech Conference the following day aimed to bring together some top-level strategic thinkers in the sector from either side of the pond. Sponsored by the Life Science Practice of Strategic Decisions Group, and introduced by Mr Gerry Cacciotti, Managing Director of the Life Sciences Practice, the keynote session was entitled 'A Compelling Vision - Mapping the Future'. Dr William Haseltine, Chairman and Chief Executive Officer of Human Genome Sciences Inc and Dr Fredrick Van Bohlen, Chairman and Chief Executive Officer of Lion Bioscience AG followed, with presentations covering the emergence of super biotechs in a maturing industry and each giving predictions of what the sector might look like in 2010.
|
